UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                  ------------

                                    FORM 8-K

                                  ------------

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of

                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                 April 19, 2006

                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

            Utah                                           87-0500306

(State or other jurisdiction of                   (IRS Employer Identification

        incorporation)                                       Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable





Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:


[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))


Item 1.01    Entry into a Material Definitive Agreement.

2006 Equity Incentive Award Plan

At the 2006 Annual Meeting of Shareholders (the "2006 Annual Meeting") of USANA
Health Sciences, Inc. (the "Company") held on April 19, 2006, the shareholders
of the Company approved the USANA Health Sciences, Inc. 2006 Equity Incentive
Award Plan (the "2006 Equity Incentive Plan"). A description of the material
terms of the 2006 Equity Incentive Plan was included in, and a copy of the 2006
Equity Incentive Plan was attached to, the Company's Definitive Proxy Statement
on Schedule 14A filed with the Securities and Exchange Commission on March 14,
2006 (the "Definitive Proxy Statement"). The 2006 Equity Incentive Plan is filed
as Exhibit 10.1 hereto, and is incorporated herein by reference.

Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
             Year.

Amendment and Restatement of Articles of Incorporation

On April 20, 2006, the Company filed Amended and Restated Articles of
Incorporation of the Company (the "Amended and Restated Articles") with the
Division of Corporations of the State of Utah (the "Division"). The Amended and
Restated Articles incorporate two amendments to the Company's Articles of
Incorproation that were approved by the shareholders of the Company on April 19,
2006 at the 2006 Annual Meeting. The first amendment added a new Article V to
the Company's Articles of Incorporation to provide that, to the fullest extent
permitted by the Utah Revised Business Corporation Act (the "Act"), directors of
the Company shall not be personally liable to the Company or its shareholders
for monetary damages for any action taken or any failure to take any action as a
director, except liability for any financial benefit received by a director to
which he or she is not entitled, an intentional infliction of harm on the
Company or its shareholders, violations of provisions of the Act relating to
unlawful distributions, or an intentional violation of criminal law (the
"Liability Amendment"). The second amendment added a new Article VI to the
Company's Articles of Incorporation to provide for the indemnification of
officers and directors of the Company against all liabilities and expenses
incurred by such persons in connection with any action, suit or proceeding by
reason of the fact that they are or were serving as a director or officer of the
Company, to the fullest extent permitted under the Act (the "Indemnification
Amendment").

The Company had previously informed its shareholders in the Definitive Proxy
Statement that if both the Liability Amendment and the Indemnification Amendment
were approved by shareholders, then instead of filing an amendment to the
Company's existing Articles of Incorporation with the Division, the Company
would file with the Division amended and restated Articles of Incorporation
containing both amendments. A copy of the Amended and Restated Articles filed
with the Division is attached hereto as Exhibit 3.1 and incorporated herein by
reference.

New Bylaws

Effective April 19, 2006, the Company's Board of Directors approved and adopted
new Bylaws of the Company (the "Bylaws"). The Bylaws were adopted to update the
Company's previous bylaws to conform to the Act. Specifically, certain of the
material changes made by the Board of Directors' adoption of the Bylaws are as
follows:

     o    Under the Bylaws, special meetings of the shareholders can be called
          at the written request of any two directors. Under the Company's
          previous bylaws, directors could call a special meeting of
          shareholders only upon the request of a majority of the directors.

     o    The Bylaws do not permit written notice of an annual or special
          shareholder meeting to be delivered more than 60 days before the date
          of the meeting. The Company's previous bylaws did not permit such
          written notice to be delivered more than 50 days before the date of
          the meeting.

     o    The Bylaws do not permit a record date for determining shareholders
          entitled to notice of or to vote at any meeting of shareholders, or
          shareholders entitled to receive payment of any distribution, to be
          more than 70 days prior to the date on which the action requiring that
          the record date be set is to be taken. The Company's previous bylaws
          did not permit such a record date to be more than 50 days prior to the
          date on which the action requiring that the record date be set was to
          be taken.

                                       2


     o    The Bylaws do not permit shares of the Company owned directly or
          indirectly by another corporation to be voted at any meeting or
          counted in determining the total number of outstanding shares at any
          given time for purposes of any meeting, if a majority of the shares
          entitled to vote for the election of directors of such corporation are
          held by the Company. The Company's previous bylaws did not contain
          such a restriction.

     o    The Bylaws do not permit the Board of Directors to consist of more
          than nine directors. The Company's previous bylaws did not contain a
          restriction on the maximum size of the Board of Directors.

     o    The Company's previous bylaws provided that a director could be
          removed from the Board of Directors for cause by a vote of a majority
          of the Board of Directors (excluding the affected director). The
          Bylaws no longer permit a director to be removed from the Board of
          Directors by other directors.

     o    The Bylaws require that the Board of Directors establish an Audit
          Committee, a Compensation Committee and a Nominating and Corporate
          Governance Committee. The Company's previous bylaws did not require
          that the Board of Directors establish these committees.

     o    The Company's previous bylaws required that the Company have a
          Treasurer and one or more Vice Presidents. The Bylaws no longer
          contain such a requirement.

     o    The Bylaws require the Company to indemnify any individual who is made
          a party to a proceeding because he or she is or was a director or
          officer of the Company against liability and/or expenses that are
          incurred in connection with such proceeding, to the maximum extent
          allowed under Utah law. The Bylaws also require that the Company
          advance expenses to any such individual in connection with any such
          proceeding, to the maximum extent permissible under Utah law. The
          Company's previous bylaws did not permit the Company to indemnify or
          reimburse any such individual for any expense incurred in connection
          with any claim or liability arising out of his or her own negligence
          or willful misconduct, and did not require that the Company advance
          expenses to such indemnified individuals.

In addition to the changes described above, the adoption of the Bylaws made
other non-material changes.

The foregoing description of the Bylaws does not purport to be complete and is
qualified in its entirety by reference to the Bylaws. A copy of the bylaws is
attached hereto as Exhibit 3.2 and incorporated herein by reference.

Item 9.01    Financial Statements and Exhibits. (furnished herewith)

             (d) Exhibits

Exhibit No.       Description
-----------       -----------

    3.1           Amended and Restated Articles of Incorporation of the Company.
    3.2           Bylaws of the Company.
    10.1          USANA Health Sciences, Inc. 2006 Equity Incentive Award Plan.


                                       3



SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
     registrant has duly caused this report to be signed on its behalf by the
     undersigned hereunto duly authorized.


                                      USANA HEALTH SCIENCES, INC.



                                      By:  /s/ Gilbert A. Fuller
                                      Gilbert A. Fuller, Chief Financial Officer


Date: April 25, 2006


                                       4